CMR Surgical unveils its new surgical robotic system after raising $100 million earlier this summer to jump-start its commercialization. Versius is designed to meet the complex requirements of minimal access surgery. It resets expectations of robotic surgery by providing a versatile system that is portable, transportable and affordable.
That design makes it easier to move between operating rooms or hospitals, with the goal of increasing the number of surgical situations. The reduced size also offers surgical teams greater physical access to the patient. Biomimicking the human arm, Versius allows surgeons the freedom of port placement, but with the benefits of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, it is hoped the new open surgeon console will reduce stress and fatigue, offering the potential to extend the careers of surgeons.
With Versius, CMR Surgical wants to remove barriers that currently exist to robotic surgery. For patients and healthcare providers alike, the benefits of minimal access surgery are compelling. The promise of reduced trauma, faster recovery and improved clinical outcomes has been the driving force behind the development of surgical robotics for decades. However, despite these benefits, robotic surgery is not yet performing the majority of available surgical procedures due to current constraints, leaving millions of patients worldwide still undergoing open surgery.
“We believe Versius represents a paradigm shift in surgery,” said Martin Frost, CEO of CMR Surgical, in a statement. “We believe Versius represents a paradigm shift in surgery. The ground-breaking design, coupled with genuine affordability, means that patients everywhere have the potential to benefit from the advantages of minimal access surgery. Versius is a great example of British innovation and its launch represents a pivotal moment in the next chapter of surgery and patient care.”
The robotic system will be used in hospitals in the UK and continental Europe in the next year, with wider international expansion shortly afterwards.
Source: CMR Surgical